ARAY Stock Analysis: Buy, Sell, or Hold?
ARAY - Accuray Incorporated
$0.29
-0.18 (-38.55%)
▼
5d:
-37.22%
30d:
-17.6%
90d:
-51.16%
WAIT
LOW Confidence
Analysis Updated: May 7, 2026 12:00 AM ET
Earnings: May 06, 2026
0d
Get Alerted When ARAY Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ARAY is down 37.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ARAY is down 37.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ARAY is currently trading at $0.29, which is considered oversold relative to its 30-day fair value range of $0.38 to $0.47. From a valuation perspective, the stock is trading at a discount (Forward PE: -2.8) compared to its historical average (39.3). At these levels, the market is pricing in 0% annual earnings growth.
Technical Outlook: Technically, ARAY is in a strong downtrend. Immediate support is located at $0.28, while resistance sits at $0.49. Short-term momentum is weak, with the stock down 38.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.52 (+761.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ARAY is in a strong downtrend. Immediate support is located at $0.28, while resistance sits at $0.49. Short-term momentum is weak, with the stock down 38.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.52 (+761.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.38 -
$0.47
Company Quality Score
40/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-38.6%)
- BULLISH: Trading 761.5% below Wall St target ($2.52)
- WARNING: Recommendation downgraded due to -37.2% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.38 -
$0.47
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.28
Resistance Level
$0.49
Current Trend
Strong Downtrend
Technical data as of
May 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.79
Wall Street Target
$2.53
(+761.5%)
Revenue Growth (YoY)
-12.0%
Earnings Growth (YoY)
-96.2%
Profit Margin
-8.2%
PE vs Historical
-2.8 vs 39.3
CHEAP
Share & Embed Analysis
Last updated: May 08, 2026 7:12 AM ET
Data refreshes hourly during market hours. Next update: 8:12 AM
Data refreshes hourly during market hours. Next update: 8:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARAY showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Neve Stephen R La
BUY
20000 shares
2025-11-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$85 | 57 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 58 HOLD |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$119 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 58 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 63 BUY |
